Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort ascending
2001 R41 PAR-99-101 SULK, ROBERTA A DELTANU, LLC ONE STEP H. PYLORI TEST--SCREENING AND INDIVIDUAL ASSAYS Complete
2004 R33 PAR-01-106 ZANGAR, RICHARD C BATTELLE PACIFIC NORTHWEST LABORATORIES PROTEOMIC IDENTIFICATION OF NAF BIOMARKERS Complete
2007 R33 RFA-CA-07-001 ROTHSTEIN, RODNEY J. COLUMBIA UNIVERSITY HEALTH SCIENCES USING SYNTHETIC DOSAGE LETHALITY TO SCREEN FOR NOVEL ANTI-TUMOR TARGETS Complete
2010 R21 RFA-CA-09-008 KASSIS, AMIN I HARVARD MEDICAL SCHOOL NOVEL BLOOD ASSAY FOR LUNG CANCER DETECTION Complete
2014 R21 RFA-CA-13-003 PETRITIS, KONSTANTINOS PHOENIX CHILDREN'S HOSPITAL PRESERVATION OF DRIED PLASMA SPOTS FOR DOWNSTREAM PROTEOMIC APPLICATIONS Complete
2017 R33 RFA-CA-16-002 WANG, YINGXIAO UNIVERSITY OF CALIFORNIA, SAN DIEGO Multiplex FRET Imaging of Kinase-Epigenome Interregulations in Live Cancer Cells Complete
2001 R21 PAR-99-102 ALLBRITTON, NANCY L UNIVERSITY OF CALIFORNIA IRVINE PROFILING RAS ACTIVATED SIGNAL TRANSDUCTION PATHWAYS Complete
2003 R33 PAR-01-104 TAYLOR, CLIVE R UNIVERSITY OF SOUTHERN CALIFORNIA RETRIEVAL OF DNA, RNA, AND PROTEIN FROM ARCHIVAL TISSUE Complete
2006 U43 RFA-CA-06-006 BALGLEY, BRIAN M. CALIBRANT BIOSYSTEMS, INC. BREAST CANCER PROTEOMIC VIA LASER-FREE MICRODISSECTION AND GEMINI TECHNOLOGIES Complete
2009 R21 RFA-CA-08-009 LIOTTA, LANCE ALLEN GEORGE MASON UNIVERSITY NANOTECHNOLOGY FOR ONE STEP CONCENTRATION AND PRESERVATION OF LABILE BIOMARKERS I Complete
2013 R33 RFA-CA-12-003 JI, HANLEE P STANFORD UNIVERSITY OLIGONUCLEOTIDE-SELECTIVE SEQUENCING FOR INTEGRATED AND RAPID CANCER GENOME ANALY Complete
2016 R43 PAR-13-327 KLUGE, JONATHAN AUGUST VAXESS TECHNOLOGIES, INC. SILK-BASED BLOOD SAMPLE STABILIZATION FOR PROSTATE CANCER DIAGNOSTICS Complete
2020 R43 PAR-18-303 WANG, SHA VIVID TECHNOLOGIES New specific and rapid assay for in situ apoptosis labeling for cancer studies Complete
2000 R33 PAR-99-100 WIGLER, MICHAEL H COLD SPRING HARBOR LABORATORY HIGH DENSITY GENE COPY NUMBER MICROARRAYS Complete
2002 R43 PAR-99-101 SHEFER, RUTH E NEWTON SCIENTIFIC, INC. A LASER-ACTIVATED REACTOR FOR BIOMEDICAL C-14-AMS Complete
2006 R21 RFA-CA-06-002 ZHANG, JIN JOHNS HOPKINS UNIVERSITY FLUORESCENT ACTIVITY SENSORS IN ANALYSIS OF ONCOGENIC P13K/AKT SIGNALING Complete
2008 R44 RFA-CA-06-006 BROWN, DAVID M AMBION DIAGNOSTICS, INC. MIRNA PROFILING IN FIXED CANCER SAMPLES Complete
2012 R21 RFA-CA-12-002 WANG, TZA-HUEI JOHNS HOPKINS UNIVERSITY PCR-FREE MULTIPLEXED DETECTION OF CIRCULATING MIRNA IN BLOOD Complete
2012 R21 RFA-CA-12-002 DAVALOS, RAFAEL VIDAL VIRGINIA POLYTECHNIC INST AND ST UNIV ISOLATION OF TUMOR INITIATING CELLS (TICS) USING CONTACTLESS DIELECTROPHORESIS Complete
2015 R43 PAR-13-327 GAU, VINCENT JEN-JR GENEFLUIDICS, INC. PROMOTE HPV SCREENING RATE WITH A NON-INVASIVE HPV POC CARTRIDGE Complete
2019 R21 RFA-CA-18-002 O'NEILL, RACHEL UNIVERSITY OF CONNECTICUT STORRS Development and Utilization of Splice-specific Antibodies Complete
2000 R21 PAR-99-100 HERLYN, DOROTHEE M WISTAR INSTITUTE MOLECULAR CLONING OF HLA CLASS II TUMOR ANTIGENS Complete
2002 R21 PAR-99-100 CLEVELAND, WILLIAM L ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS ROBOTIC PREPARATION OF CDNA SINGLE CELLS Complete
2005 R21 RFA-CA-05-003 HYSLOP, TERRY THOMAS JEFFERSON UNIVERSITY NONLINEAR MODELS OF MRNA EXPRESSION IN CANCER BY RT-PCR Complete
2008 R21 RFA-CA-07-035 NELSON, EDWARD L UNIVERSITY OF CALIFORNIA-IRVINE APPLICATION OF A NOVEL NANOTECHNOLOGY FOR MOLECULAR PROFILING OF TUMOR CELLULAR E Complete
2011 R21 RFA-CA-10-005 MCDONALD, JOHN F GEORGIA INSTITUTE OF TECHNOLOGY USE OF NANOGELS TO TARGET DELIVERY OF SIRNA TO CANCER CELLS IN MICE Complete
2015 R21 RFA-CA-14-003 VO-DINH, TUAN DUKE UNIVERSITY NANOPLASMONICS-BASED MOLECULAR ANALYSIS TOOL FOR MOLECULAR BIOMARKERS OF CANCER Complete
2018 R33 RFA-CA-17-011 KONRY, TANIA TALI NORTHEASTERN UNIVERSITY Determining treatment sensitivity in B cell lymphoma by novel microfluidics-based NK cell immunogenicity platform Complete
1999 R43 PAR-98-066 MOSTERT, MICHAEL J ECHELON BIOSCIENCES, INC. PHOSPHOINOSITIDE 3-KINASE ASSAYS IN CANCER DIAGNOSIS Complete
2001 R43 PAR-99-101 PICCOLI, STEVEN P MOLECULAR STAGING, INC. ROLLING CIRCLE AMPLIFICATION ANALYSIS OF CERVICAL CELLS Complete
2004 R33 PAR-01-106 SINGER, ROBERT H ALBERT EINSTEIN COL OF MED YESHIVA UNIV FISH AND CHIPS: SINGLE CELL EXPRESSION OF CANCER GENES Complete
2007 R33 RFA-CA-07-001 BERTICS, PAUL JOHN UNIVERSITY OF WISCONSIN-MADISON MOLECULAR ANALYSIS USING LIQUID CRYSTAL TECHNOLOGY Complete
2010 R21 RFA-CA-09-008 SZMACINSKI, HENRYK UNIVERSITY OF MARYLAND BALTIMORE METHOD FOR DETECTION OF SECRETED PROTEINS IN SINGLE CELL ASSAYS Complete
2014 R33 RFA-CA-13-002 WEISS, WILLIAM A UNIVERSITY OF CALIFORNIA, SAN FRANCISCO INTEGRATING MASS CYTOMETRIC AND TRANSCRIPTOMIC PROFILES OF SOLID TUMORS Complete
2017 R33 RFA-CA-16-004 ISSADORE, DAVID AARON UNIVERSITY OF PENNSYLVANIA Rapid unbiased isolation and in situ RNA analysis of circulating tumor cells using a magnetic micropore-based diagnostic chip Complete
2001 R21 PAR-99-102 SPEICHER, DAVID W. WISTAR INSTITUTE NOVEL COMPREHENSIVE PROTEOME ANALYSES OF METASTASIS Complete
2003 R33 PAR-01-104 LAM, KIT S UNIVERSITY OF CALIFORNIA DAVIS SMALL MOLECULE MICROARRAYS FOR INTRACELLULAR PROTEINS Complete
2007 R21 RFA-CA-07-001 HUANG, FAQING UNIVERSITY OF SOUTHERN MISSISSIPPI FOLATE RECEPTOR-MEDIATED SIRNA DELIVERY TO CANCER CELLS Complete
2009 R21 RFA-CA-08-009 FOWLER, CAROL B AMERICAN REGISTRY OF PATHOLOGY, INC. RECOVERY OF PROTEINS FROM FORMALIN-FIXED TISSUES UNDER HIGH HYDROSTATIC PRESSURE Complete
2013 R33 RFA-CA-12-003 KAMM, ROGER D. MASSACHUSETTS INSTITUTE OF TECHNOLOGY MICROFLUIDIC 3D ASSAYS FOR METASTATIC CANCER Complete
2016 R43 PAR-13-327 GUNDERSON, KEVIN L ENCODIA, INC. Development of Reagents for Sequencing Proteins and Protein Fragments on a Next-Generation DNA Sequencer Complete
2000 R33 PAR-99-100 CONTAG, CHRISTOPHER H STANFORD UNIVERSITY VISIBLE ANIMAL MODELS OF NEOPLASTIC DISEASE Complete
2002 R43 PAR-99-101 HENKENS, ROBERT W ALDERON BIOSCIENCES, INC. INNOVATIVE TECHNOLOGY FOR GENE EXPRESSION STUDIES Complete
2006 R21 RFA-CA-06-003 FRANKENBURG, SHOSHANA HADASSAH-HEBREW UNIVERSITY MEDICAL CTR TARGETED ANTIGEN DELIVERY FOR CANCER IMMUNOTHERAPY Complete
2008 R44 RFA-CA-07-008 DOLINGER, DAVID LEE IQUUM, INC. RAPID POINT-OF-CARE ASSAY FOR DETECTING HIGH RISK HUMAN PAPILLOMAVIRUS Complete
2006 R21 RFA-CA-06-003 MEYER, TOBIAS STANFORD UNIVERSITY DISSECTION OF THE MODULAR STRUCTURE OF CANCER SIGNALING SYSTEMS Complete
2009 R21 RFA-CA-08-006 LESSNICK, STEPHEN L. UNIVERSITY OF UTAH ANTIBODY-BASED DETECTION OF TRANSLOCATIONS IN PEDIATRIC CANCER Complete
2012 R21 RFA-CA-12-002 TAO, NONGJIAN ARIZONA STATE UNIVERSITY-TEMPE CAMPUS CHARGE SENSITIVE OPTICAL DETECTION FOR HIGH THROUGHPUT STUDY OF SMALL MOLECULES Complete
2016 R21 RFA-CA-15-002 BURGETT, ANTHONY WG UNIVERSITY OF OKLAHOMA NORMAN MASS SPECTROMETRY DETECTION OF DRUGS IN SINGLE BLADDER CANCER CELLS FROM PATIENTS Complete
2019 R21 RFA-CA-18-002 MONTAGNA, CRISTINA ALBERT EINSTEIN COLLEGE OF MEDICINE Development of a high-resolution mapping platform for HPV DNA integration in premalignant lesions Complete

Pages